Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-09-27FDA Approved: LORAZEPAM — Supplemental Application (Aurolife Pharma LLC)
The FDA approved a supplemental application for lorazepam from Aurolife Pharma LLC, enabling the commercialization of a generic Lorazepam pr…
-
FDA approval · 2023-08-21FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Venlafaxine from BluePoint Laboratories, confirming a generic venlafaxine product (venlafaxine h…
-
FDA approval · 2023-08-21FDA Approved: VENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for Venlafaxine from Sun Pharmaceutical Industries, Inc., updating the generic product under ANDA 07…
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for venlafaxine hydrochloride, a generic antidepressant.
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
FDA approved a supplemental application for venlafaxine hydrochloride by Vertical Pharmaceuticals, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-08-18FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for escitalopram oxalate from Rising Pharma Holdings, Inc., marking a supplemental approval for …
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Yaopharma Co., Ltd.)
FDA approved a supplemental application for venlafaxine hydrochloride from Yaopharma Co., Ltd., enabling the generic drug to be marketed. Th…
-
FDA approval · 2023-08-18FDA Approved: DRIZALMA SPRINKLE — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
The FDA approved Sun Pharmaceutical's supplemental NDA for Drizalma Sprinkle (duloxetine), adding a sprinkle-form formulation and related la…
-
FDA approval · 2023-08-18FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) from Viatris Specialty LLC. The approval updates the …
-
FDA approval · 2023-08-18FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for paroxetine submitted by Padagis US LLC. This action represents an additional regulatory appr…
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Venlafaxine Hydrochloride from Dr. Reddy's Laboratories Limited for a generic venlafaxine hydroc…
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Venlafaxine from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. under an ANDA.
-
FDA approval · 2023-08-17FDA Approved: HYDROXYZINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved an original application for hydroxyzine hydrochloride from Rising Pharma Holdings, Inc., confirming a generic antihistamine pro…
-
FDA approval · 2023-08-16FDA Approved: DOXEPIN — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for a generic doxepin product (DOXEPIN) from Zydus Lifesciences Limited.
-
FDA approval · 2023-08-09FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc., indicating an update to the produ…
-
FDA approval · 2023-07-21FDA Approved: PREGABALIN — Supplemental Application (Eskayef Pharmaceuticals Limited)
FDA approved a supplemental application for pregabalin (generic) submitted by Eskayef Pharmaceuticals Limited.
-
FDA approval · 2023-06-30FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Alprazolam from Sandoz Inc, indicating a regulatory approval related to a generic product.
-
FDA approval · 2023-06-27FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Micro Labs Limited)
FDA approved the original abbreviated new drug application for doxepin hydrochloride from Micro Labs Limited. Doxepin hydrochloride is used …
-
FDA approval · 2023-06-26FDA Approved: PREGABALIN — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' supplemental application for pregabalin under ANDA 207623, indicating approval of changes to this gene…
-
FDA approval · 2023-06-23FDA Approved: ALPRAZOLAM EXTENDED RELEASE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for an extended-release formulation of alprazolam, adding the extended-release dosage form under the…
-
FDA approval · 2023-06-21FDA Approved: PREGABALIN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for pregabalin from Ascend Laboratories, LLC (ANDA207799), indicating approval of a supplemental fil…
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for a generic pregabalin from Rising Pharma Holdings, Inc., authorizing its marketing for the same i…
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for pregabalin from Alembic Pharmaceuticals Inc., enabling a generic version to be marketed.
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN — Supplemental Application (Dr.Reddys Laboratories Inc)
FDA approved a supplemental application for pregabalin from Dr. Reddy's Laboratories Inc., authorizing a generic version under the approved …
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN CAPSULES, CV — Supplemental Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s supplemental application for Pregabalin Capsules, CV, enabling the marketing of a generic pregabalin capsule p…